HIMS downgraded, agilon upgraded at Citi in 2025 Health Tech review

Citi downgraded telehealth company Hims & Hers Health (NYSE:HIMS) to Sell from Neutral and upgraded value-based care provider agilon health (NYSE:AGL) to Neutral from Sell on Friday as part of its 2025 outlook for the U.S. Health Tech